Table 8. Per caput effective dose (mSv) to different age-related groups of the Aosta Valley male and Female population between 2001 and 2008.
Age | Sex | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 |
Total population | 0.45 | 0.55 | 0.67 | 0.78 | 0.85 | 0.94 | 0.94 | 1.02 | |
All | Female | 0.39 | 0.44 | 0.56 | 0.66 | 0.74 | 0.83 | 0.83 | 0.89 |
Male | 0.51 | 0.67 | 0.78 | 0.91 | 0.96 | 1.06 | 1.06 | 1.16 | |
Years <2 | Female | 0.01 | 0.02 | 0.07 | 0.05 | 0.08 | 0.01 | 0.02 | 0.01 |
Male | 0.22 | 0.12 | 0.10 | 0.11 | 0.05 | 0.02 | 0.02 | 0.01 | |
2 ≤ years <10 | Female | 0.02 | 0.02 | 0.03 | 0.05 | 0.06 | 0.06 | 0.01 | 0.01 |
Male | 0.02 | 0.05 | 0.06 | 0.04 | 0.08 | 0.02 | 0.01 | 0.08 | |
10 ≤ years <20 | Female | 0.08 | 0.08 | 0.07 | 0.10 | 0.10 | 0.12 | 0.18 | 0.18 |
Male | 0.08 | 0.16 | 0.17 | 0.16 | 0.19 | 0.17 | 0.17 | 0.19 | |
20 ≤ years <30 | Female | 0.11 | 0.13 | 0.16 | 0.27 | 0.25 | 0.31 | 0.36 | 0.41 |
Male | 0.16 | 0.22 | 0.27 | 0.30 | 0.35 | 0.38 | 0.47 | 0.48 | |
30 ≤ years <40 | Female | 0.20 | 0.22 | 0.27 | 0.31 | 0.38 | 0.39 | 0.47 | 0.49 |
Male | 0.23 | 0.29 | 0.42 | 0.39 | 0.42 | 0.46 | 0.67 | 0.59 | |
40 ≤ years <50 | Female | 0.38 | 0.47 | 0.54 | 0.54 | 0.66 | 0.70 | 0.72 | 0.92 |
Male | 0.38 | 0.44 | 0.52 | 0.63 | 0.70 | 0.71 | 0.90 | 1.21 | |
50 ≤ years <70 | Female | 0.60 | 0.65 | 0.82 | 0.94 | 1.12 | 1.24 | 1.14 | 1.23 |
Male | 0.86 | 1.04 | 1.21 | 1.35 | 1.47 | 1.76 | 1.56 | 1.81 | |
Years ≥70 | Female | 0.91 | 0.98 | 1.34 | 1.61 | 1.68 | 1.96 | 1.93 | 1.93 |
Male | 1.78 | 2.55 | 2.75 | 3.47 | 3.40 | 3.55 | 3.27 | 3.24 |